肺部超声在指导急性左心衰竭患者呋塞米使用中的价值

    Application value of furosemide guided by lung ultrasound in the treatment of acute left heart failure

    • 摘要: 目的:探讨肺部超声在指导急性左心衰竭患者呋塞米使用中的价值。方法:70例急性左心衰竭的患者随机分为2组。对照组34例经验性使用呋塞米,观察组36例给予肺部超声指导下使用呋塞米。比较2组患者所需利尿剂总量、最大日尿量和治疗后B型尿钠肽下降程度。结果:观察组患者所需呋塞米的总量少于对照组(P<0.01),2组患者最大日尿量和治疗后B型尿钠肽下降程度差异均有统计学意义(P<0.01)。结论:肺部超声能评估急性左心衰竭患者的治疗效果,并可以指导急性左心衰的治疗,降低呋塞米的使用总量。

       

      Abstract: Objective: To investigate the application value of furosemide guided by lung ultrasound in the treatment of acute left heart failure. Methods: Seventy patients with acute left heart failure were randomly divided into the observation group(36 cases) and control group(34 cases). The control group were empirically treated with furosemide, the observation group were treated with furosemide guided by lung ultrasound. The total required diuretics, maximum daily urine amount and the decreasing degree of B-type natriuretic peptide after treatment between two group were compared. Results: The total required furosemide in observation group was less than that in control group(P<0.01). The differences of maximum daily urine amount and the decreasing degree of B-type natriuretic peptide after treatment in two groups were statistically significant(P<0.01). Conclusions: Lung ultrasound can evaluate the therapeutic effects of furosemide in patients with acute left heart failure, guide the treatment of acute left heart failure, and reduce the use amount of furosemide.

       

    /

    返回文章
    返回